.It's an uncommonly occupied Friday for biotech IPOs, along with Zenas BioPharma, MBX and Bicara The...
.Atea Pharmaceuticals' antiviral has neglected one more COVID-19 test, yet the biotech still holds o...
.Neurocrine Biosciences' schizophrenia course pivot has failed. The biotech was actually not able to...
.Sanofi has actually created a late entry to the radioligand party, paying for one hundred thousand ...
.After F2G's initial effort to receive a new training class of antifungal to market was actually wre...
.Moderna has pledged to cut R&D costs by $1.1 billion through 2027. The decision to retract the b...
.Merely 4 months after Sanofi wager $80 thousand in ahead of time cash on Fulcrum Therapeutics' losm...
.Cancer cells business Oncternal Rehabs is actually folding all its scientific tests and also laying...
.Roche is actually storing out chances that its own injectable weight problems possibility can ultim...
.Novo Nordisk has elevated the lid on a period 1 test of its oral amylin as well as GLP-1 receptor c...